inōtiv Corporate Presentation June 2023

NHP Supply Update 01 T0 We are continuing to identify, import, and sell NHPs from sources other than Cambodia suppliers, including Vietnam and Mauritius 02 We believe that we have an adequate supply of NHPs to meet our internal DSA client demands 03 Pricing environment remains strong due to constrained supply of NHPs and inelastic demand Biologic drugs generally require NHPs by the FDA to progress into human clinical trials 04 15 | We remain committed to selling only purpose-bred NHPs and thoroughly assessing all supply sources CORPORATE PRESENTATION inōtiv analyze, answer. advance.

View entire presentation